4th Quarter - Report

CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. for GLOBAL HEALTHY LIVING FOUNDATION

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733 Medicare Part B coverage policy Health Reimbursement Arrangements

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Senior Legislative Fellow, Senate HELP Committee Policy Fellow, NIH/NHGRI Office of the Director
LINDSEY TRISCHLER New —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 1316 (115th), S. 2554 (115th), H.R. 1703 (115th), S. 2553 (115th), H.R. 6733 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.